✨ 4 results found - Searched 21184 records in 3ms.
Tesis
Status Fungsional, Rasio Limfosit Monosit dan Rasio Trombosit Limfosit sebagai Faktor Prognosis Kesintasan Satu Tahun Pasien Lanjut Usia dengan Kanker Paru Karsinoma Bukan Sel Kecil Stadium IIIB-IV
2024 | BY Ratna Nurhayati - Aulia Rizka - Noorwati Sutandyo - Cleopas Martin Rumende- Functional Status, Lymphocyte to Monocyte Ratio and Platelet to Lymphocyte Ratio as a Prognostic Factor of 1-year Survival in Elderly with Non-Small Cell Lung Stage IIIB-IV.
- Nomor Panggil T24053fk
Tesis
Karakteristik dan kesintasan 90 hari pasien-pasien sindrom vena kava superior di Rumah Sakit Cipto Mangunkusumo dan Rumah Sakit Kanker Dharmais
2013 | BY Malikul Chair - Zulkifli Amin - Andhika Rachman - Noorwati Sutandyo- Characteristic and 90 days survival of superior vena cava syndrome patients in Cipto Mangunkusumo and Dharmais Cancer Hospital.
- Nomor Panggil T13038fk
Tesis
Perbandingan rejimen kemoterapi cisplatin-etoposide dengan cisplatin-docetaxel dalam hal kesintasan 2 tahun dan progression-free survivalpasien kanker paru stadium lanjut jenis non-small cell
2012 | BY Salman Paris Harahap - Noorwati Sutandyo - Cleopas Martin Rumende - Hamzah Shatri- Comparison of chemotherapy effect between cisplatin-etoposide and cisplatin-docetaxed in 2-year survival rate and progression free survival rate of advanced non-small cell lung cancer patients.
- Nomor Panggil T12376fk
Disertasi
Peran MiR-10b, MiR-21, SuPAR dan PAI-1 Sebagai Prediktor Respons Terapi dan Progresivitas pada Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK).
2017 | BY Lyana Setiawan - Noorwati Sutandyo - Siti Boedina Kresno - Rahajuningsih Setiabudy- The Role of MiR-10b, MiR-21, Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), and Plasminogen Activator Inhibitor (PAI)-1 as Predictors of Treatment Response and Progressivity in Non-Small Cell Lung Cancer (NSCLC).
- Nomor Panggil D17020fk